Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Multiple drugs

Bleeding and thromboembolic events following drug-drug pharmacokinetic interaction: 26 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
  • * Drug interaction
Literatur
Zurück zum Zitat Wang T-F, et al. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. Journal of Thrombosis and Haemostasis 19: 2068-2081, No. 8, Aug 2021. Available from: URL: http://doi.org/10.1111/jth.15367CrossRef Wang T-F, et al. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. Journal of Thrombosis and Haemostasis 19: 2068-2081, No. 8, Aug 2021. Available from: URL: http://​doi.​org/​10.​1111/​jth.​15367CrossRef
Metadaten
Titel
Multiple drugs
Bleeding and thromboembolic events following drug-drug pharmacokinetic interaction: 26 case reports
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02254-7

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Methotrexate

Case report

Methotrexate

Case report

Apixaban

Case report

Tacrolimus